New spinout of Novartis-acquired startup announces $77M funding

The team behind ophthalmology startup Vedere Bio Inc. is launching a new venture — and they’re keeping the name: Vedere Bio II Inc. With $77 million in funding, it’s got a bold mission to restore vision in patients who have gone blind due to genetic mutations affecting the retina. Read More

Read More

Zoom Telephonics seeks to move its stock listing to Nasdaq

One of the reasons companies traded over the counter seek to move to the standard exchanges is broaden their exposure to potential investors. Last year, cable modem maker Zoom Telephonics merged with Minim Inc., which develops and sells an IoT home security platform. Read More

Read More